Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)

INTRODUCTION: In a study conducted by Annane, patients with septic shock and unresponsive to adrenocorticotropic hormone stimulation receiving low-dose steroid therapy had prolonged survival but not significantly improved 28-day mortality. The present study examines intravenous steroid use in PROWES...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Howard, Laterre, Pierre-Francois, Bates, Becky, Qualy, Rebecca L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297614/
https://www.ncbi.nlm.nih.gov/pubmed/16277711
http://dx.doi.org/10.1186/cc3778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297614/
https://www.ncbi.nlm.nih.gov/pubmed/16277711
http://dx.doi.org/10.1186/cc3778

Ejemplares similares